Bausch Health Cos EBITDA Margin 2010-2024 | BHC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bausch Health Cos (BHC) over the last 10 years. The current EBITDA margin for Bausch Health Cos as of September 30, 2024 is .
| Bausch Health Cos EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-09-30 |
$9.47B |
$2.69B |
28.44% |
| 2024-06-30 |
$9.20B |
$2.42B |
26.34% |
| 2024-03-31 |
$8.97B |
$2.40B |
26.79% |
| 2023-12-31 |
$8.76B |
$2.29B |
26.17% |
| 2023-09-30 |
$8.54B |
$1.72B |
20.09% |
| 2023-06-30 |
$8.35B |
$1.97B |
23.64% |
| 2023-03-31 |
$8.15B |
$1.79B |
22.00% |
| 2022-12-31 |
$8.12B |
$1.95B |
23.97% |
| 2022-09-30 |
$8.13B |
$2.56B |
31.51% |
| 2022-06-30 |
$8.19B |
$2.93B |
35.80% |
| 2022-03-31 |
$8.33B |
$2.52B |
30.28% |
| 2021-12-31 |
$8.43B |
$2.06B |
24.39% |
| 2021-09-30 |
$8.45B |
$1.75B |
20.74% |
| 2021-06-30 |
$8.48B |
$1.69B |
19.92% |
| 2021-03-31 |
$8.04B |
$2.01B |
25.03% |
| 2020-12-31 |
$8.03B |
$2.56B |
31.92% |
| 2020-09-30 |
$8.04B |
$1.55B |
19.32% |
| 2020-06-30 |
$8.11B |
$1.51B |
18.62% |
| 2020-03-31 |
$8.60B |
$1.84B |
21.44% |
| 2019-12-31 |
$8.60B |
$1.94B |
22.50% |
| 2019-09-30 |
$8.50B |
$3.09B |
36.40% |
| 2019-06-30 |
$8.43B |
$3.07B |
36.38% |
| 2019-03-31 |
$8.40B |
$2.82B |
33.59% |
| 2018-12-31 |
$8.38B |
$0.51B |
6.13% |
| 2018-09-30 |
$8.42B |
$0.47B |
5.63% |
| 2018-06-30 |
$8.51B |
$0.41B |
4.77% |
| 2018-03-31 |
$8.61B |
$0.71B |
8.26% |
| 2017-12-31 |
$8.72B |
$3.11B |
35.66% |
| 2017-09-30 |
$8.96B |
$3.45B |
38.48% |
| 2017-06-30 |
$9.22B |
$2.56B |
27.71% |
| 2017-03-31 |
$9.41B |
$2.53B |
26.86% |
| 2016-12-31 |
$9.67B |
$2.42B |
24.99% |
| 2016-09-30 |
$10.03B |
$2.42B |
24.12% |
| 2016-06-30 |
$10.34B |
$3.74B |
36.15% |
| 2016-03-31 |
$10.65B |
$3.97B |
37.27% |
| 2015-12-31 |
$10.45B |
$4.14B |
39.63% |
| 2015-09-30 |
$9.91B |
$4.24B |
42.74% |
| 2015-06-30 |
$9.18B |
$4.20B |
45.74% |
| 2015-03-31 |
$8.49B |
$3.90B |
45.98% |
| 2014-12-31 |
$8.21B |
$3.69B |
44.91% |
| 2014-09-30 |
$8.05B |
$3.36B |
41.69% |
| 2014-06-30 |
$7.53B |
$2.28B |
30.25% |
| 2014-03-31 |
$6.59B |
$2.00B |
30.33% |
| 2013-12-31 |
$5.77B |
$1.70B |
29.39% |
| 2013-09-30 |
$4.63B |
$1.28B |
27.67% |
| 2013-06-30 |
$3.97B |
$1.47B |
37.10% |
| 2013-03-31 |
$3.69B |
$1.29B |
34.86% |
| 2012-12-31 |
$3.48B |
$1.10B |
31.67% |
| 2012-09-30 |
$3.21B |
$1.08B |
33.50% |
| 2012-06-30 |
$2.93B |
$1.08B |
36.94% |
| 2012-03-31 |
$2.72B |
$1.02B |
37.60% |
| 2011-12-31 |
$2.43B |
$0.94B |
38.73% |
| 2011-09-30 |
$2.29B |
$0.83B |
36.24% |
| 2011-06-30 |
$1.90B |
$0.47B |
24.83% |
| 2011-03-31 |
$1.53B |
$0.31B |
20.37% |
| 2010-12-31 |
$1.18B |
$0.17B |
14.04% |
| 2010-09-30 |
$0.91B |
$0.17B |
18.61% |
| 2010-06-30 |
$0.91B |
$0.35B |
38.23% |
| 2010-03-31 |
$0.87B |
$0.30B |
34.56% |
| 2009-12-31 |
$0.82B |
$0.32B |
38.86% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.012B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
